Tenon Medical, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
331K
on 2026-06-30, from 13K on 2024-03-31 10-Q ↗
Earlier counts are adjusted for the 1-for-8 and 1-for-35 reverse splits; each bar's tip shows the count as filed.
a raise that quarter, at its price
Newest
$100.0M
S-3 of 2026-08-11. Sales under the at-the-market programme filed with it are not stated apart. S-3 ↗
$4.4M
A.G.P./Alliance Global Partners, agreement of 2026-08-11. No at-the-market sales statement read from a 10-Q or 10-K. S-3 ↗
Warrants
7,143
Warrants of every class as tagged in the XBRL facts on 2023-06-30, exercise price $1568.00. Adjusted for the 1-for-8 and 1-for-35 reverse splits. 10-K ↗
Cash
0.6 quarters
$1.7M on 2026-06-30 ÷ $2.9M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-08-27 | Private placement incl. 0.60M pre-funded | 1,195,220 | not read | $3.0M | 8-K ↗ |
| 2026-06-29 | Public offering incl. 5.53M pre-funded, with warrants at $0.38 | 11,052,631 | $0.38 | $4.2M | 424B4 ↗ |
| 2025-11-10 | Private placement | 2,217,904 | not read | $2.9M | 8-K ↗ |
| 2025-03-25 | Public offering incl. 0.12M pre-funded | 733,500 | $2.00 | $1.5M | 424B5 ↗ |
| 2025-03-25 | Public offering incl. 0.66M pre-funded | 1,271,500 | $2.00 | $2.5M | 424B5 ↗ |
| 2025-03-25 | Registered direct offering incl. 0.12M pre-funded | 237,000 | not read | $1.5M | 8-K ↗ |
| 2025-03-25 | Registered direct offering incl. 0.66M pre-funded | 1,313,000 | not read | $2.5M | 8-K ↗ |
Also on file: $4.3M convertible notes, 2026-03-11 8-K ↗ · a 1-for-35 reverse split, 2026-08-06 8-K ↗